Skip to content
Screener

Harmony Biosciences Holdings, Inc. HRMY Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Alkermes logo
AlkermesALKS
$69.45M-4.4%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$23.01M-5.5%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.42M-42.5%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$73.85M+31.2%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.5M-5.6%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$1.4M—

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$2.26B+13.1%
Enterprise value$1.83B+12.9%
P/E15.5×+4.5×
P/S2.5×-0.1×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:16 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056720
LeasesClassificationMarch 31, 2026December 31, 2025
Assets
Operating lease right-of-use assetsOther noncurrent assets$5,3885,344
Liabilities
Operating lease liability, current portionOther current liabilities$1,2671,073
Operating lease liability, long-termOther long-term liabilities4,5284,512
Total operating lease liabilities$$5,7955,585

Item 1. Financial Statements

FAQ

What is Harmony Biosciences Holdings, Inc.'s operating lease liabilities (total)?
Harmony Biosciences Holdings, Inc. (HRMY) reported operating lease liabilities (total) of $5.8M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s operating lease liabilities (total) changed year-over-year?
Harmony Biosciences Holdings, Inc.'s operating lease liabilities (total) increased by 225.2% year-over-year, from $1.78M to $5.8M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s operating lease liabilities (total)?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s operating lease liabilities (total) has grown at a 10.4% compound annual growth rate (CAGR), from $3.76M to $5.59M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Harmony Biosciences Holdings, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude